Celltrion
068270.KS
101,31 €
Share price
-0.79%
Change (1 day)
-21.40%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): 2,83 €
According to Celltrion 's latest financial reports the company's current EPS (TTM) is 2,74 €. In 2022 the company made an earnings per share (EPS) of 2,66 € a decrease over its 2021 EPS that were of 3,16 €.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | 2,83 € | 6.39% |
| 2022 | 2,66 € | -15.84% |
| 2021 | 3,16 € | 12.77% |
| 2020 | 2,81 € | 70.79% |
| 2019 | 1,64 € | 15.63% |
| 2018 | 1,42 € | -33.13% |
| 2017 | 2,13 € | 141.17% |
| 2016 | 0,88 € | 8.28% |
| 2015 | 0,81 € | 11.28% |
| 2014 | 0,73 € | 16.37% |
| 2013 | 0,63 € | -67.42% |
| 2012 | 1,93 € | 84.22% |
| 2011 | 1,05 € | 62.13% |
| 2010 | 0,65 € | 80.61% |
| 2009 | 0,36 € | -559.63% |
| 2008 | -0,07780 € | -123.16% |
| 2007 | 0,34 € |